I founded ENLIGHTEN SCIENTIFIC after 24-years in the pharmaceutical industry. I spent most of my time on late phase formulation and device development of metered-dose inhalers (MDIs). This is one of the most — if not the most — complex delivery platforms. In the early 2000s, I led the development and approval of one of the most successful North American MDI products — ADVAIR® HFA Inhalation Aerosol. In the mid-2010s, I transitioned to the manufacturing organization. MDIs require very careful supply change control and it was common for arising issues to be dealt with in a trial-and-error way. In contrast, I used my colloid science expertise to identify and implement much more robust solutions with significantly less resource. The experiences and expertise gained working with MDIs proved valuable for helping resolve issues with other dosage forms. I became a technical expert for many international product development and manufacturing teams.

Prior to starting my career in the pharmaceutical industry, I obtained my PhD in colloid science at the University of Bristol, widely recognized as one of the premier world-class centers of excellence for colloid and interface science. For my research, I invented Phase Analysis Light Scattering (PALS) which is now the de facto method for determining the zeta potential of dilute liquid dispersions. Major manufacturers of PALS instruments include Malvern Panalytical, Brookhaven Instruments, and Wyatt Technologies.